Kolexia
Louveau Baptiste Pharmacien
Louveau Baptiste
Pharmacien
Hôpital Saint-Louis
Paris, France
62 Activités
209 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Mélanome Tumeurs cutanées Lymphome T cutané Lymphomes Lymphome T Arthrite Inflammation Syndrome de Sézary Arthrite juvénile

Collaborateurs

Voir plus
Lebbe Celeste
Lebbe Celeste
Hôpital Saint-Louis, Paris, France
Battistella Maxime
Battistella Maxime
Hôpital Saint-Louis, Paris, France
Jouenne Fanélie
Jouenne Fanélie
Hôpital Saint-Louis, Paris, France
Baroudjian Barouyr
Baroudjian Barouyr
Hôpital Saint-Louis, Paris, France

Industries

Voir plus
Roche
1 collaboration(s)
Dernière en 2018
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
Failure of second challenge with Mogamulizumab in CCR4-positive cutaneous T-cell lymphoma.
The British journal of dermatology   23 février 2024
Combined PDE4+MEK inhibition shows antiproliferative effects in NRASQ61 mutated melanoma preclinical models.
Melanoma research   22 décembre 2023
Nécrolyse épidermique toxique associée au mogamulizumab chez un patient atteint du syndrome de Sézary
Journées dermatologiques de Paris 2023   01 décembre 2023
Graft-versus-lymphoma effect in skin after allogeneic hematopoietic stem cell transplantation for Sézary syndrome.
European journal of dermatology : EJD   02 novembre 2023
Severe relapses of cutaneous T-cell lymphoma after treatment of chronic graft-versus-host disease with ruxolitinib.
Journal of the European Academy of Dermatology and Venereology : JEADV   10 août 2023
PKPD relationship of ipilimumab plus nivolumab combination in patients with advanced melanoma
Abstracts of the Annual Meeting of French Society of Pharmacology and Therapeutics, 12–14 June 2023, Limoges, France   07 juin 2023
Ex vivo histoculture drug response assay to uncover therapeutic opportunities in NRASQ61 mutated melanoma
Abstracts of the Annual Meeting of French Society of Pharmacology and Therapeutics, 12–14 June 2023, Limoges, France   07 juin 2023
Innovative therapeutic strategies in BRAF-mutated metastatic melanoma: Clinical evaluation of the anti-BRAF + anti-CDK4/6 combination and validation of Kindlin-3 as a new relevant target
Abstracts of the Annual Meeting of French Society of Pharmacology and Therapeutics, 12–14 June 2023, Limoges, France   07 juin 2023
TERT Expression Induces Resistance to BRAF and MEK Inhibitors in BRAF-Mutated Melanoma In Vitro.
Cancers   24 mai 2023
Microsecretory adenocarcinoma of the skin, a novel type of sweat gland carcinoma: Report of three additional cases.
Journal of cutaneous pathology   08 mars 2023